Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Content
    • Current
    • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Cytotoxicity of Dental Compounds towards Human Oral Squamous Cell Carcinoma and Normal Oral Cells

TEHO KOH, MAMORU MACHINO, YUKIO MURAKAMI, NAOKI UMEMURA and HIROSHI SAKAGAMI
In Vivo January 2013, 27 (1) 85-95;
TEHO KOH
1Division of Oral Diagnosis, Meikai University School of Dentistry, Sakado, Saitama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MAMORU MACHINO
1Division of Oral Diagnosis, Meikai University School of Dentistry, Sakado, Saitama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUKIO MURAKAMI
1Division of Oral Diagnosis, Meikai University School of Dentistry, Sakado, Saitama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NAOKI UMEMURA
2Division of Pharmacology, Meikai University School of Dentistry, Sakado, Saitama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROSHI SAKAGAMI
2Division of Pharmacology, Meikai University School of Dentistry, Sakado, Saitama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sakagami@dent.meikai.ac.jp
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Aim: The cytotoxicity of four dental compounds, hydroquinone, benzoquinone, eugenol and phtharal towards human oral squamous cell carcinoma (OSCC) cell lines, normal human oral cells (gingival fibroblast, pulp cell, periodontal ligament fibroblast) and skin keratinocytes was investigated. Materials and Methods: Viable cell number was determined by the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) method. The concentration that reduced the viable cells by 50% (CC50) and the concentration that increased the viability of UV-irradiated cells to 50% (EC50) were determined from the dose-response curves. The tumor-specificity index (TS) was determined by the ratio of the mean CC50 for normal cells to the one for tumor cells. Apoptosis induction was monitored by assay of internucleosomal DNA fragmentation and caspase-3/-7 activation. Results: When both oral OSCC and normal oral cells were incubated for 4 h with any of hydroquinone, benzoquinone, eugenol and phtharal, irreversible cell growth inhibition, accompanied by cell death occurred without induction of apoptotic markers, although caspase-3/-7 activation was observed at 6 h or later. These compounds exhibited very low tumor-specificity (TS=0.4-1.3), as compared with anticancer drugs (5-fluorouracil, melphalan, peplomycin) (TS=4.1-9.7). Human skin keratinocytes were the most resistant to these drugs, and a long incubation time was required to induce irreversible growth inhibition. However, all dental compounds exhibited very low tumor-specificity (TS=0.4-2.4), compared to human skin keratinocytes and OSCC cell lines. None of the dental compounds exhibited any hormetic growth stimulation, nor protected the cells from UV-induced damage. Conclusion: These results suggest that apoptosis is not involved in the early stage of growth inhibition induced by dental compounds.

  • Eugenol
  • hydroquinone
  • benzoquinone
  • phtharal
  • oral cells
  • squamous cell carcinoma

Hydroquinone, benzoquinone, eugenol and phtharal are popular disinfectants or cosmetics used in dentistry (Figure 1). Hydroquinone is a component of composite resins and heat-curing resins and is used as a polymerization inhibitor. Benzoquinone is a component of light-cured resins and is used as a photosensitizer. Eugenol is a component of dental cements, sealers and dental impression materials, and has antiseptic, analgesic and sedative actions. Phtharal is a high-level disinfectant and expected to replace glutaraldehyde (Glutaral®). These compounds contain highly reactive hydroxyl or ketone groups. For the safe use of these compounds in dentistry, it is crucial to investigate their cytotoxicity towards the cells of the oral cavity.

It has been reported that eugenol and hydroquinone induced apoptosis of human promyelocytic leukemia cells (1). However, studies of their cytotoxicity towards oral cancer cells are limited (2-9). Furthermore, as far as we know, the relative cytotoxicity against both oral normal and tumor cell lines has not yet been reported. Therefore, we investigated all four compounds for their cytotoxicity towards three human oral squamous cell carcinoma (OSCC) cell lines (HSC-2, HSC-4, Ca9-22), three human oral normal mesenchymal cells [gingival fibroblast (HGF), pulp cell (HPC) and periodontal ligament fibroblast (HPLF)] and human skin epithelial fibroblasts (HEKn), and their apoptosis-inducing capability in OSCC cell lines.

It has been reported that many toxic substances, environmental hormones, inorganic compounds, and even irradiation modulate the growth of cultured cells in a bi-phasic fashion, stimulating or inhibiting the growth of various cultured cells at lower and higher concentrations, respectively. This growth-stimulating effect at lower concentrations is known as hormesis (10, 11). However, we recently found that Chinese herbal extracts (12), sodium fluoride (13), 2-aminotropones (14), tropolones (15), azulenes (16) and a low level of CO2 laser irradiation (17, 18), induced very little hormesis in oral cells, or only for certain durations and concentrations. To confirm the generality of the occurrence of hormesis, we investigated whether dental compounds induce hormesis in oral cells.

Using a newly-established evaluation system for UV-induced cellular damage (15, 16), we have reported that several natural polyphenols protect cells from UV-induced cytotoxicity (19). We investigated here whether these dental compounds also exhibit such an anti-UV activity.

Materials and Methods

Materials. The following chemicals and materials were obtained from the indicated companies: RPMI-1640, Dulbecco's Modified Eagle's Medium (DMEM) from Gibco BRL, Grand Island, NY, USA; fetal bovine serum (FBS), phtharal (MW=134), melphalan, 3-[4,5-dimethylthiazol-2yl]-2,5-diphenyltetrazolium bromide (MTT), phenylmethylsulfonyl fluoride (PMSF) from Sigma Chemical Ind., St. Louis, MO, USA); hydroquinone (MW=110), benzoquinone (MW=108), eugenol (MW=164), dimethylsulfoxide (DMSO) from Wako Pure Chemical, Osaka, Japan; peplomycin sulfate from Santa Cruz Biotechnology, Santa Cruz, CA, USA; 5-fluorouracil (5-FU) from Kyowa, Tokyo, Japan; RNase A, Proteinase K, ethidium bromide, agarose S from Nippon Gene Co., Ltd., Toyama, Japan; DNA molecular marker from Bayou Biolabs, Harahan, LA, USA; 6-well plates, 24-well plates, 96-microwell plates from Becton Dickinson, Franklin Lakes, NJ, USA; substrate of caspase-3, DEVD-pNA (p-nitroanilide) from MBL, Aichi Prefecture, Japan; HuMedia-KG2 from Kurabo, Osaka, Japan; Hydroquinone and benzoquinone were dissolved in DMSO at 100 mM, whereas eugenol and phtharal were dissolved in DMSO at 200 mM before use, and diluted with medium.

Cell culture. HL-60 cells (Riken, Tsukuba, Japan) were cultured at 37°C in RPMI-1640 supplemented with 10% heat-inactivated FBS. Human OSCC cell lines (HSC-2, HSC-4, Ca9-22) were kindly provided by Professor Nagumo, Showa University, Japan. These adherent cells were cultured in DMEM supplemented with 10% heat-inactivated FBS. Normal human oral cells, HGF, HPC and HPLF were prepared from periodontal tissues, as previously reported (15), and used at 8-15 population doubling levels (PDL). HEKn (purchased from Kurabo, Osaka, Japan) were cultured in HuMedia-KG2 supplemented with insulin, human recombinant epidermal growth factor, (hEGF), hydrocortisone, gentamicin, amphotericin B and bovine pituitary gland extract (BPE).

Assay for cytotoxic activity. All cells were inoculated at 3×103 cells/well in 96-microwell plates (Becton Dickinson Labware, NJ, USA), unless otherwise stated. After 48 h, the medium was removed by suction with an aspirator, and replaced with 0.1 ml of fresh medium containing different concentrations of the test compounds (0, 1.85, 3.9, 7.8, 15.6, 31.25, 62.5, 125, 250, 500 μM for hydroquinone and benzoquinone; 0, 3.9, 7.8, 15.6, 31.25, 62.5, 125, 250, 500, 1000 μM for eugenol and phtharal). The cells were incubated for another 4, 24 or 48 h, and the relative viable cell number was then determined by the MTT method, as previously reported (16). The 50% cytotoxic concentration (CC50) was determined from the dose-response curve and the mean value of CC50 for each cell type was calculated from 3-6 independent experiments. The tumor-specificity index (TS) was determined by the following equation: TS (OSCC vs. mesenchymal cells)=(CC50[HGF] + CC50[HPC] + CC50[HPLF])/(CC50[HSC-2] + CC50[HSC-4] + CC50[Ca9-22]).

TS (OSCC vs. epithelial cells)=(CC50[HEKn])/(CC50[HSC-2] + CC50[HSC-4] + CC50[Ca9-22]) ×3.

TS (OSCC vs. all normal cells)=(CC50[HGF] + CC50[HPC] + CC50[HPLF] + CC50[HEKn])/(CC50[HSC-2] + CC50[HSC-4] + CC50[Ca9-22]) × (3/4).

Assay for hormesis. The hormetic response was evaluated by the maximum response in each dose-response curve, as described previously (15, 16).

Assay for DNA fragmentation. Near-confluent cells on 6-well dish were incubated for 4 h with different concentrations of test compounds (0, 15.6, 31.25, 62.5, 125, 250 μM for hydroquinone and benzoquinone, 0, 62.5, 125, 250, 500, 1000 μM for eugenol and phtharal). Cells were washed once with phosphate-buffered saline without Ca2+ and Mg2+ [PBS(–)] and lysed with lysate buffer [50 mM Tris-HCl (pH 7.8), 10 mM EDTA, 0.5% (w/v) sodium N-lauroylsalcosinate]. The lysate was incubated with 0.4 mg/ml RNase A and 0.8 mg/ml proteinase K for 1-2 h at 50°C, and then mixed with 50 μl NaI solution [7.6 M NaI, 20 mM EDTA-2Na, 40 mM Tris-HCl, pH 8.0], and 100 μl of ethanol. After centrifugation for 20 min at 20,000 ×g, the precipitate was washed with 1 ml of 70% ethanol and dissolved in TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 3-5). The sample (10-20 μl) was then applied to 2% agarose gel electrophoresis in TBE buffer (89 mM Tris-HCl, 89 mM boric acid, 2 mM EDTA, pH 8.0) (20). DNA molecular marker (Takara, Shiga, Japan) and the DNA from apoptotic HL-60 cells induced by ultraviolet (UV) irradiation were used for calibration. The DNA fragmentation pattern was examined in photographs taken under UV illumination.

Assay for caspase activation. Cells were incubated for 4 h without or with CC50, CC50×2, or CC50×4 of each compound. Cells were then washed with PBS(–) and lysed with lysis solution (MBL, Nagoya, Japan). After resting cells for 10 min on ice and centrifugation for 5 min at 10,000 ×g, the supernatant was collected. The lysate (50 μl, equivalent to 100 μg protein) was mixed with 50 μl 2× reaction buffer (MBL) containing substrates for caspase-3 (DEVD-pNA). After incubation for 4 h at 37°C, the absorbance at 405 nm of the liberated chromophore pNA was measured by a microplate reader (20).

Assay for western blotting. HSC-2 cells were treated for 1, 3, 6, 12 or 24 h with CC50×2 of each dental compound. The cleavage of poly ADP-ribose polymerase (PARP) was measured using a Promega PARP (Asp 214) human-specific antibody (Cell Signaling Technology, Inc., Boston, MA, USA). In brief, cells were washed in ice-cold PBS(–), scraped, collected in lysis buffer [20 mM HEPES (pH 7.4), 1% Triton-X 100, 150 mM NaCl, 1.5 mM MgCl2, 12.5 mM β-glycerophosphate, 2 mM EGTA, 10 mM NaF, 2 mM dithiothreitol (DTT), 1 mM Na3VO4, 1 mM PMSF, 1× protease inhibitor]. The cell lysates (equivalent to 30 μg protein) were applied to a 8% SDS-polyaclylamide gel electrophoresis (SDS-PAGE) and the protein bands in the gels were transferred onto polyvinylidene difluoride membranes. The membranes blocked with 5% (w/v) non-fat dry milk, incubated with primary antibody [anti-cleaved PARP1 (Cell Signaling Technology, Beverly, MA, USA) (dilution, 1:1000), anti-β-actin antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) (dilution, 1:10000)], and then with horseradish peroxidase-conjugated anti-mouse or anti-rabbit secondary antibodies (21).

Assay for UV protection. HSC-2 cells were incubated for 48 h to attach to the 96-microwell plate. The medium was replaced with PBS(–) containing 0, 0.016, 0.031, 0.063, 0.125, 0.25, 0.5, 1, 2 or 4 mM hydroquinone, benzoquinone or eugenol, or 0, 0.125, 0.25, 0.5, 1, 2, 4, 8, 16 or 32 mM sodium ascorbate. The plate was immediately placed at 21 cm of distance from a UV lamp (wavelength 253.7 nm) and cells were then exposed to UV irradiation (6 J/m2/min) for 1 min. The media were replaced with fresh DMEM plus 10% FBS and cells were cultured for a further 48 h to determine the viable cell number (15, 16, 19).

Statistical analysis. The difference between two groups was evaluated by the Student's t-test.

Results

Tumor–specificity. The four dental compounds exhibited a cytotoxic effect, but not a cytostatic effect on human OSCC cell lines (HSC-2, HSC-4, Ca9-22) (Figure 2A) and human oral normal cells (HPC, HGF, HPLF) (Figure 2B). From the dose-response curves, the CC50 value was determined (Table I). Benzoquinone exhibited the highest cytotoxicity, followed by hydroquinone, phtharal and then eugenol. These compounds had comparable magnitudes of cytotoxicity, regardless of the treatment time (4, 24 or 48 h) (Figure 1, Table I), indicating that the irreversible growth inhibition accompanied by cell death had already occurred during the first 4 h.

The tumor–specificity of these compounds was next investigated. Hydroquinone and benzoquinone were slightly more cytotoxic towards normal oral cells (HGF, HPC, HPLF), as compared with OSCC cell lines (HSC-2, HSC-4, Ca9-22) (Table I), yielding TS values of 0.39-0.76. Eugenol and phtharal had comparable cytotoxicity towards normal oral cells and OSCC cell lines, yielding TS values of 1.02-1.28. On the other hand, 5-fluorouracil, melphalan and peplomycin had much higher TS values (TS=3.43, 4.09 and 9.73, respectively) (Table I).

HEKn were the most resistant to these drugs, and therefore a long incubation period was needed to induce irreversible cell death. When comparing cytotoxicity towards HEKn and towards OSCC cell lines, all dental compounds had a very low level of tumor–specificity (TS=0.4-2.4), as compared with the anticancer drugs (TS=7.3-23.5) (Table I).

Hormetic response. All four dental compounds, at their lowest concentration, induced only slight hormetic growth-stimulatory effects on all three OSCC cell lines (hormetic response=0-9.7%), three oral normal cell types (hormetic response=0-26.2%) and skin keratinocytes (hormetic response=0-57.4%), regardless of incubation time (4, 24 or 48 h) (Table II).

Type of cell death. Since the growth inhibition or cell death signal was triggered within 4 h after treatment with any of the four dental compounds, next, whether 4 h-treatment induces apoptosis markers (i.e. internucleosoal DNA fragmentation by activated DNase(s) and caspase-3) (22) in both tumor and normal cells was investigated. It was unexpected that these compounds did not induce internucleosomal DNA fragmentation in the three OSCC cell lines (Figure 3A) and three normal oral cell types (Figure 3B), in contrast to the DNA laddering pattern observed in apoptotic HL-60 cells, induced by UV irradiation (indicated by UV in Figure 3A and B). Similarly, these compounds at the concentrations of CC50, CC50×2 or CC50×4 did not induce caspase-3 activation, in contrast to higher caspase-3 activation (p<0.01) induced in apoptotic HL-60 cells (Figure 4). Western blot analysis demonstrated that caspase-3/-7 activation, detected by the production of cleaved PARP, was observed only at later stages (6-24 h after treatment) (Figure 5).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Chemical structure of the four dental compounds studied.

  • Download figure
  • Open in new tab
  • Download powerpoint
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Cytotoxicity of the four dental compounds studied towards human oral squamous cell carcinoma cell lines (A) and normal oral cells (B). Cells were treated for 4, 24, or 48 h with the indicated concentrations of hydroquinone (HQ), benzoquinone (BQ), eugenol (EUG) and phtharal (PHA). The viable cell number was then determined by the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) method, and expressed as a parcentage to that of the control. Each value represents the mean±S.D. from three independent experiments.

  • Download figure
  • Open in new tab
  • Download powerpoint
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Effect of the four dental compounds studied on DNA fragmentation in human oral squamous cell carcinoma cell lines (A) and normal oral cells (B). Cells were incubated for 4 h with the indicated concentrations of hydroquinone (HQ), benzoquinone (BQ), eugenol (EUG) and phtharal (PHA). DNA was then extracted and subjected to agarose gel electrophoresis. MA: DNA marker; UV: DNA from HL-60 cells induced to apoptosis by UV irradiation.

Anti-UV activity. Exposure of HSC-2 cells to UV irradiation for 1 min killed nearly all cells after culture in regular medium for 48 h (Figure 6). Although the addition of sodium ascorbate (positive control) at the time of UV irradiation protected the cells from UV-induced damage (EC50=0.38 mM, CC50>32 mM, SI=84.2), neither hydroquinone, benzoquinone nor eugenol exhibited such an anti-UV activity (SI<1.0) (Figure 6).

Discussion

The present study demonstrated, to our knowledge for the first time, that these four dental compounds induced rapid irreversible growth inhibition and cell death on both oral OSCC cell lines and normal oral cells. The concentration of eugenol and phtharal used in the present study (CC50=696-796 μM and 144-415 μM, respectively) was close to that used in clinical dentistry (600 and 400 μM, respectively). The minimum treatment time required for cell death induction was found to be 4 h or less. During 4 h after treatment, apoptosis markers such as internucleosomal DNA fragmentation and caspase-3 activation were not observed. Caspase-3/-7 activation was observed only at 6 h or later. These data suggest that apoptosis may not be involved in the early stage of growth inhibition and cell death induction by dental compounds. This result is not consistent with previous finding that hydroquinone induced apoptotic cell death via mitochondrial intrinsic pathway in HL-60 cells (7), suggesting that the type of cell death induced may depend on the cell types as well as the chemical structure of inducers (23).

We found that these four dental compounds, especially hydroquinone and benzoquinone, exhibited potent cytotoxicity towards both oral normal cells below 50 μM (Table I). Hydroquinone, benzoquinone and phtharal (log p=0.394, 0.62 and 0.395, respectively) have higher hydrophilicity than eugenol (log p=2.403). Judging from these log p values, eugenol may be more easily incorporated into the cells. Hydroquinone has been reported to increase reactive oxygen species (ROS) generation and dysfunction of mitochondria [inhibition of manganese superoxide dismutase (SOD) induction)] in the HL-60 promyelocytic leukemia cells, which was inhibited by N-acetyl-L-cysteine, a popular antioxidant (7). The apoptotic effect of EUG is also accompanied by the elevation of ROS (24, 25). Hydroquinone and benzoquinone induced oxidative stress such as glutathione depletion, and the nuclear factor (erythroid-derived 2)-like 2 (Nrf2) and antioxidant response element (ARE) pathways are essential for protection against hydroquinone, and benzoquinone-induced toxicity (26). Cytotoxicity of phtharal has not yet been reported. Identification of early metabolic changes after exposure to these compounds may contribute to our understanding of how to combat their cytotoxicity.

We used HEKn due to the difficulty of establishing oral keratinocytes in our laboratory. To maintain HEKn, the use of nutritionally enriched HuMedia-KG2 medium, which contains insulin, human recombinant EGF (hEGF) and hydrocortisone and bovine pituitary gland extract (BPE), was inevitable (27). The presence of such growth factors may have worked to counteract apoptosis and thus delayed the onset of cytotoxic action.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Cytotoxic activity of dental compounds towards human oral squamous cell carcinoma, human oral cells and human skin keratinocytes. Each value represents mean±S.D. of triplicate assays.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table II.

Effect of dental compounds on the induction of hormesis in human oral squamous cell carcinoma cell lines, oral normal cells and skin keratinocytes.

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Effect of the four dental compounds studied on caspase-3 activity in human oral squamous cell carcinoma cell lines and normal oral cells. Cells were incubated for 4 h without (control), or with 50% cytotoxic concentration (CC50), CC50×2, or CC50×4 of dental compounds and then assayed for caspase-3 activity (expressed as 405 nm of cleaved product for each substrate). Data are expressed as the mean±S.D. **Significantly different from the HL-60 control value (p<0.01). UV: HL-60 cells were exposed to 1 min UV irradiation, followed by 3 h of incubation.

We investigated whether dental compounds have any beneficial effects on these cells. However, we found that the four dental compounds had marginal hormetic effects on OSCC and normal cells, regardless of the treatment time (0-48 h) (Table II). Taken together with our previous data, oral cells seem to have very weak responsiveness to hormetic stimuli. These compounds did not protect cells from UV-induced cellular injury. We are also investigating their possible anti-inflammatory action, since eugenol exhibited potent anti-inflammatory action (28, 29).

In conclusion, the present study demonstrated the rapid cytotoxic action of eugenol at the concentration used for the topical application in the dentistry, suggesting the importance of careful use of this drug. Further investigation is necessary to elucidate the target molecule of eugenol.

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

Activation of caspase-3/-7 by dental compounds. HSC-2 cells were incubated for the indicated times with 50% cytotoxic concentration (CC50)×2 of dental compounds, and the production of cleaved product of poly ADP-ribose polymerase (PARP) was detected by western blot analysis.

Figure 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 6.

Effect of UV irradiation on the viability of cultured HSC-2 cells. HSC-2 cells were exposed to UV irradiation (6 J/m2/min, 1 min) for 1 min in PBS (–) containing the indicated concentrations of hydroquinone (HQ), benzoquinone (BQ), eugenol (EUG) or sodium ascorbate. After removing the medium or PBS(–), the cells were incubated for 48 h in fresh culture medium. The viable cells were then determined by the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) method, and the absorbance (relative viable cell number) was determined at 540 nm. Each value represents the mean of triplicate assays.

  • Received September 18, 2012.
  • Revision received October 31, 2012.
  • Accepted November 1, 2012.
  • Copyright © 2013 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

References

  1. 1.↵
    1. Atsumi T,
    2. Fujisawa S,
    3. Satoh K,
    4. Sakagami H,
    5. Iwakura I,
    6. Ueha T,
    7. Sugita Y,
    8. Yokoe I
    : Cytotoxicity and radical intensity of eugenol, isoeugenol or related dimmers. Anticancer Res 20: 2519-2524, 2000.
    OpenUrlPubMed
  2. 2.↵
    1. Okada N,
    2. Satoh K,
    3. Atsumi T,
    4. Tajima M,
    5. Ishihara M,
    6. Sugita Y,
    7. Yokoe I,
    8. Sakagami H,
    9. Fujisawa S
    : Radical-modulating activity and cytotoxic activity of synthesized eugenol-related compounds. Anticancer Res 20: 2955-2960, 2000.
    OpenUrlPubMed
  3. 3.
    1. Terasaka H,
    2. Takayama F,
    3. Satoh K,
    4. Fujisawa S,
    5. Sakagami H
    : Effect of antioxidants on radical intensity and cytotoxicicity of hydroquinone. Anticancer Res 20: 3357-3362, 2000.
    OpenUrlPubMed
  4. 4.
    1. Fujisawa S,
    2. Atsumi T,
    3. Satoh K,
    4. Kadoma Y,
    5. Ishihara M,
    6. Okada N,
    7. Kashiwagi Y,
    8. Yokoe I,
    9. Sakagami H
    : Radical generation, radical-scavenging activity and cytotoxicity of eugenol-related compounds. In Vitro Mol Toxicol 13: 269-279, 2000.
    OpenUrlPubMed
  5. 5.
    1. Fujisawa S,
    2. Atsumi T,
    3. Kadoma Y,
    4. Sakagami H
    : Antioxidant and prooxidant action of eugenol-related compounds and their cytotoxicity. Forum “Phenolic compounds: Free radical mechanisms of toxicity, catalysis and protection”. Toxicology 177: 39-54, 2002
    OpenUrlCrossRefPubMed
  6. 6.
    1. Fujisawa S,
    2. Atsumi T,
    3. Satoh K,
    4. Sakagami H
    : Interaction between 2-ethoxybenzoic acid (EBA) and eugenol, and its cytotoxicity. J Dental Res 82: 43-47, 2003.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Terasaka H,
    2. Morshed SRM,
    3. Hashimoto K,
    4. Sakagami H,
    5. Fujisawa S
    : Hydroquinone-induced apoptosis in HL-60 cells. Anticancer Res 25: 161-170, 2005.
    OpenUrlAbstract/FREE Full Text
  8. 9.↵
    1. Okada N,
    2. Hirata A,
    3. Murakami Y,
    4. Shoji M,
    5. Sakagami H,
    6. Fujisawa S
    : Induction of cytotoxicity and apoptosis and inhibition of cyclooxygenase-2 gene expression by eugenol-related compounds. Anticancer Res 25: 3263-3270, 2005.
    OpenUrlAbstract/FREE Full Text
  9. 10.↵
    1. Calabrese EJ
    : Paradigm lost, paradigm found: The re-emergence of hormesis as a fundamental dose–response model in the toxicological sciences. Environ Pollut 138: 379-412, 2005.
    OpenUrlCrossRefPubMed
  10. 11.↵
    1. Cook RC,
    2. Calabrese EJ
    : The importance of hormesis to public health. Environ Health Perspect 114: 1631-1635, 2006.
    OpenUrlPubMed
  11. 12.↵
    1. Chu Q,
    2. Kobayashi M,
    3. Hashimoto K,
    4. Satoh K,
    5. Kanamoto T,
    6. Terakubo S,
    7. Nakashima H,
    8. Wang Q,
    9. Sakagami H
    : Antitumor potential of three herbal extracts against human oral squamous cell lines. Anticancer Res 29: 3211-3220, 2009.
    OpenUrlAbstract/FREE Full Text
  12. 13.↵
    1. Satoh R,
    2. Kishino K,
    3. Morshed SRM,
    4. Takayama F,
    5. Otsuki S,
    6. Suzuki F,
    7. Hashimoto K,
    8. Kikuchi H,
    9. Nishikawa H,
    10. Yasui T,
    11. Sakagami H
    : Changes in fluoride sensitivity during in vitro senescence of human normal oral cells. Anticancer Res 25: 2085-2090, 2005.
    OpenUrlAbstract/FREE Full Text
  13. 14.↵
    1. Wakabayashi H,
    2. Narita T,
    3. Suga A,
    4. Sakagami H
    : Hormetic response of cultured normal and tumor cells to 2-aminotropone derivatives. In Vivo 24: 39-44, 2010.
    OpenUrlAbstract/FREE Full Text
  14. 15.↵
    1. Kantoh K,
    2. Ono M,
    3. Nakamura Y,
    4. Nakamura Y,
    5. Hashimoto K,
    6. Sakagami H,
    7. Wakabayashi H
    : Hormetic and anti-radiation effects of tropolone-related compounds. In Vivo 24: 843-852, 2010.
    OpenUrlAbstract/FREE Full Text
  15. 16.↵
    1. Ueki J,
    2. Shimada A,
    3. Sakagami H,
    4. Wakabayashi H
    : Hormetic and UV-protective effects of azulene-related compounds. In Vivo 25: 41-48, 2011.
    OpenUrlAbstract/FREE Full Text
  16. 17.↵
    1. Iwasaka K,
    2. Tomita K,
    3. Ozawa Y,
    4. Katayama T,
    5. Sakagami H
    : Effect of CO2 laser irradiation on hormesis induction in cultured oral cells. In Vivo 25: 93-98, 2011.
    OpenUrlAbstract/FREE Full Text
  17. 18.↵
    1. Iwasaka K,
    2. Hemmi E,
    3. Tomita K,
    4. Ishihara S,
    5. Katayama T,
    6. Sakagami H
    : Effect of CO2 laser irradiation on hormesis induction in human pulp and periodontal ligament fibroblasts. In Vivo 25: 787-793, 2011.
    OpenUrlAbstract/FREE Full Text
  18. 19.↵
    1. Nanbu T,
    2. Matsuta T,
    3. Sakagami H,
    4. Shimada J,
    5. Maki J,
    6. Makino T
    : Anti-UV activity of Lentinus edodes mycelia extract (LEM). In Vivo 25: 733-740, 2011.
    OpenUrlAbstract/FREE Full Text
  19. 20.↵
    1. Otsuki S,
    2. Sugiyama K,
    3. Amano O,
    4. Yasui T,
    5. Sakagami H
    : Negative regulation of NaF-induced apoptosis by Bad-CAII complex. Toxicology 287: 131-136, 2011.
    OpenUrlPubMed
  20. 21.↵
    1. Masuda Y,
    2. Suzuki R,
    3. Sakagami H,
    4. Umemura N,
    5. Ueda J,
    6. Shirataki Y
    : Induction of non-apoptotic cell death by Odontioda Marie Noel ‘Velano’ extracts in human oral squamous cell carcinoma cell line. In Vivo 26: 265-270, 2012.
    OpenUrlAbstract/FREE Full Text
  21. 22.↵
    1. Nagata S,
    2. Kawane K
    : Nucleases in programmed cell death. Methods Enzymol 442: 271-287, 2008.
    OpenUrlPubMed
  22. 23.↵
    1. Sakagami H,
    2. Kawase M,
    3. Wakabayashi H,
    4. Kurihara T
    : Factors that affect the type of cell death induced by chemicals. Autophagy 3: 493-495, 2007.
    OpenUrlPubMed
  23. 24.↵
    1. Jaqanathan SK,
    2. Mazumdar A,
    3. Mondhe D,
    4. Mandal M
    : Apoptotic effect of eugenol in human colon cancer cell lines. Cell Biol Int 35: 607-615, 2011.
    OpenUrlPubMed
  24. 25.↵
    1. Vidhya N,
    2. Devaraj SN
    : Induction of apoptosis by eugenol in human breast cancer cells. Indian J Exp Biol 49: 871-878, 2011.
    OpenUrlPubMed
  25. 26.↵
    1. Rubio V,
    2. Zhang J,
    3. Valderde M,
    4. Rojas E,
    5. Shi ZZ
    : Essential role of Nrf2 in protection against hydroquinone- and benzoquinone-induced cytotoxicity. Toxicol In Vitro 25: 521-529, 2011.
    OpenUrlPubMed
  26. 27.↵
    1. Kobayashi K,
    2. Ohno S,
    3. Uchida S,
    4. Amano O,
    5. Sakagami H,
    6. Nagasaka H
    : Cytotoxicity and type of cell death induced by local anesthetics against human oral normal and tumor cells. Anticancer Res 32: 2925-2934, 2012.
    OpenUrlAbstract/FREE Full Text
  27. 28.↵
    1. Magalhães CB,
    2. Riva DR,
    3. DePaula LJ,
    4. Brando-Lima A,
    5. Koatz VL,
    6. Leal-Cardoso JH,
    7. Zin WA,
    8. Faffe DS
    : In vivo anti-inflammatory action of eugenol on lipopolysaccharide-induced lung injury. J Appl Physiol 108: 845-851, 2010.
    OpenUrlAbstract/FREE Full Text
  28. 29.↵
    1. Bachiega TF,
    2. de Sousa JP,
    3. Bastos JK,
    4. Sforcin JM
    : Clove and eugenol in noncytotoxic concentrations exert immunomodulatory/anti-inflammatory action on cytokine production by murine macrophages. J Pharm Pharmacol 64: 610-616, 2012.
    OpenUrlPubMed
View Abstract
PreviousNext
Back to top

In this issue

In Vivo: 27 (1)
In Vivo
Vol. 27, Issue 1
January-Ferbruary 2013
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cytotoxicity of Dental Compounds towards Human Oral Squamous Cell Carcinoma and Normal Oral Cells
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
7 + 6 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Cytotoxicity of Dental Compounds towards Human Oral Squamous Cell Carcinoma and Normal Oral Cells
TEHO KOH, MAMORU MACHINO, YUKIO MURAKAMI, NAOKI UMEMURA, HIROSHI SAKAGAMI
In Vivo Jan 2013, 27 (1) 85-95;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Cytotoxicity of Dental Compounds towards Human Oral Squamous Cell Carcinoma and Normal Oral Cells
TEHO KOH, MAMORU MACHINO, YUKIO MURAKAMI, NAOKI UMEMURA, HIROSHI SAKAGAMI
In Vivo Jan 2013, 27 (1) 85-95;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Cytotoxicity and Pro-Inflammatory Action of Chemo-Mechanical Caries-removal Agents Against Oral Cells
  • Re-evaluation of Anti-inflammatory Potential of Eugenol in IL-1{beta}-stimulated Gingival Fibroblast and Pulp Cells
  • Changes of Metabolic Profiles in an Oral Squamous Cell Carcinoma Cell Line Induced by Eugenol
  • Google Scholar

More in this TOC Section

  • Drug Screening of Potential Multiple Target Inhibitors for Estrogen Receptor-α-positive Breast Cancer
  • Combination Cancer Therapy of a Del1 Fragment and Cisplatin Enhanced Therapeutic Efficiency In Vivo
  • TBX15 rs98422, DNM3 rs1011731, RAD51B rs8017304, and rs2588809 Gene Polymorphisms and Associations With Pituitary Adenoma
Show more Experimental Studies

Similar Articles

Keywords

  • Eugenol
  • hydroquinone
  • benzoquinone
  • phtharal
  • oral cells
  • squamous cell carcinoma
In Vivo

© 2021 In Vivo

Powered by HighWire